Point72 Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$118M Buy
225,510
+99,075
+78% +$47.3M 0.21% 139
2025
Q4
$73.6M Buy
126,435
+85,202
+207% +$43.5M 0.12% 269
2025
Q3
$18.9M Sell
41,233
-69,644
-63% -$26M 0.04% 574
2025
Q2
$33.6M Buy
110,877
+45,017
+68% +$13.4M 0.08% 336
2025
Q1
$21.8M Buy
+65,860
New +$21.6M 0.06% 429
2024
Q3
Sell
-40,958
Closed -$11.5M 2313
2024
Q2
$11.5M Sell
40,958
-52,613
-56% -$12.5M 0.04% 563
2024
Q1
$25M Buy
+93,571
New +$22M 0.07% 381
2023
Q4
Sell
-172,900
Closed -$25.3M 2614
2023
Q3
$25.3M Buy
+172,900
New +$32.5M 0.09% 340
2023
Q2
Sell
-3,993
Closed -$967K 2591
2023
Q1
$967K Buy
+3,993
New +$1.09M ﹤0.01% 1113
2022
Q4
Sell
-22,876
Closed -$1.49M 1753
2022
Q3
$1.49M Buy
+22,876
New +$1.59M 0.01% 994
2021
Q4
Sell
-30,100
Closed -$2.4M 1232
2021
Q3
$2.4M Buy
+30,100
New +$2.6M 0.01% 773
2020
Q2
Sell
-78,900
Closed -$5.27M 943
2020
Q1
$5.27M Buy
+78,900
New +$6.57M 0.04% 376
2019
Q4
Sell
-30,521
Closed -$2.63M 1142
2019
Q3
$2.63M Sell
30,521
-27,379
-47% -$2.57M 0.02% 557
2019
Q2
$6.07M Buy
57,900
+37,133
+179% +$3.98M 0.04% 470
2019
Q1
$2.6M Sell
20,767
-32,233
-61% -$4.01M 0.01% 671
2018
Q4
$5.97M Sell
53,000
-41,800
-44% -$6.47M 0.03% 519
2018
Q3
$20.3M Buy
+94,800
New +$23.8M 0.11% 295
2018
Q2
Sell
-39,900
Closed -$4.66M 1127
2018
Q1
$4.66M Sell
39,900
-80,100
-67% -$9.89M 0.02% 589
2017
Q4
$11M Buy
+120,000
New +$6.85M 0.06% 427

Other funds holding MDGL